Triple-negative breast cancer (TNBC), defined by the absence of receptors for estrogen, progesterone and human epithelial receptor 2 (HER2), is a recalcitrant disease in need of effective therapy (1, 2).
implanted into the mammary gland of nude mice. The tumors grew and metastasized to lymph nodes. The lymphnode metastases were harvested and orthotopically reimplanted into the mammary gland of nude mice. After the orthotopic tumors grew, the tumor was resected leaving residual cancer cells, which grew and metastasized to lymph nodes. The lymph-node metastases were harvested, cut and orthotopically re-implanted into the mammary gland of nude mice for additional cycles and then isolated. The isolated variant was highly invasive in the mammary gland and metastasized to lymph nodes in 10 out of 12 mice compared to two out of 12 of the parental cell line (3) .
The present report describes isolation of an intermediately-aggressive variant of MDA-MB-231-RFP and compares it to the highly-aggressive model, as well as to the parental cell line, showing that the set of variants can serve as models of metastatic progression of TNBC.
Materials and Methods
Cell culture. Parental and metastatic variants of the TNBC MDA-MB-231P-RFP cell line were maintained and cultured in Dulbecco's modified Eagle's medium (DMEM) on plastic with 10% fetal bovine serum and 5% penicillin/streptomycin.
Mice. Athymic nude mice (AntiCancer Inc., San Diego, CA, USA) were kept in a barrier facility under HEPA filtration. Mice were fed with autoclaved laboratory rodent diet (Tecklad LM-485, Envigo, Indianapolis, IN, USA). All animal studies were conducted in accordance with the principles and procedures outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals under assurance A3873-01.
Establishment of intermediately-and highly-metastatic variants by serial orthotopic implantation. Initially, MDA-MB-231-RFP cells (1×10 7 cells/site) were injected subcutaneously into the flank of 5 nude mice. For orthotopic transplantation, 7-mm 3 fragments of the harvested subcutaneous tumor were grafted into a mammary gland of 5 nude mice. After growth, the tumor was resected. Residual cancer cells grew into a tumor which was harvested and divided into fragments and re-implanted into a mammary gland. After the tumor metastasized to lymph nodes, it was harvested and divided into fragments and re-implanted into mammary gland. After growth, the orthotopic tumor was resected. The residual cancer cells formed primary and metastatic tumors. The metastasis was harvested and divided into fragments re-implanted into the mammary gland. Highly-metastatic MDA-MB-231-RFP tumors were developed after seven orthotopic transplantations described above. Intermediatelymetastatic variants of MDA-MB-231-RFP were isolated by serial orthotopic transplantation three times (3) (4) (5) (6) .
In vivo whole-body/whole-tumor imaging. The OV100 small animal imaging system (Olympus Corp., Tokyo, Japan), was used. The OV100 contains an MT-20 light source (Olympus Biosystems, Planegg, Germany) and DP70 CCD camera (Olympus), for whole body, as well as subcellular imaging in live mice (7) (8) (9) . The optics of the OV100 have been specially developed for macroimaging as well as microimaging with high light-gathering capacity. Four individually optimized objective lenses, parcentered and parfocal, provide a 105-fold magnification range. High-resolution images were captured directly on a PC (Fujitsu Siemens, Munich, Germany). Images were processed for contrast and brightness and analyzed with the use of Paint Shop Pro 8 and CellR (10) (11) (12) (13) (14) (15) .
Confocal laser scanning microscopy (CLSM) was performed using the FV1000 (Olympus Corp.) with 2-laser diodes (473 nm and 559 nm). A 4x (0.20 numerical aperture immersion) objective lens and 20 x (0.95 numerical aperture immersion) objective lens (Olympus) were used. Scanning and image acquisition were controlled by Fluoview software (Olympus) (16) . Figure 1C, 2C ) are shown as means±standard deviation (SD). For comparison between two groups, significant differences were determined using the Student's t-test. P-values of less than 0.05 were considered significant.
Statistical analysis. Data for fluorescence intensity (

Results and Discussion
The degree of malignancy of isolated variants of MDA-MB-231-RFP depended on the extent of orthotopic transplantation. Intermediately-and highly-metastatic variants of MDA-MB-231-RFP were developed by serial orthotopic transplantation in the mammary gland using lymph-node metastasis. Serial transplantation resulted in MDA-MB-231-RFP cells which produced significantly larger tumors compared with parental MDA-MB-231-RFP cells. Serial orthotopic implantation three times resulted in → Figure 1 . (10) (11) (12) (13) (14) (15) . intermediately-metastatic variants of MDA-MB-231-RFP. The highly-metastatic MDA-MB-231-RFP variant serially transplanted seven times grew significantly faster at the primary site ( Figure 1A and B) , and metastasized more to lymph nodes compared with parental MDA-MB-231-RFP and the intermediately-metastatic variant ( Figure 1C) . The highly-metastatic MDA-MB-231-RFP variant significantly metastasized to the lung to a greater extent compared with parental MDA-MB-231-RFP and the intermediately metastatic variant of MDA-MB-231-RFP (Figure 2A-C) .
Selection of weakly-, intermediately and highly-metastatic variants of MDA-MB-231-RFP triple-negative breast cancer: primary growth and lymph-node metastasis. For orthotopic transplantation, fragments of MDA-MB-231P-RFP tumors were used for grafting into mammary glands of nude mice. After the orthotopic tumor was resected, residual cancer cells were allowed to grow into tumors and metastasis which were harvested and re-implanted into mammary glands of other nude mice. After metastasis to the lymph nodes, the metastatic tumors were harvested and reimplanted into mammary glands of nude mice. Intermediately-metastatic MDA-MB-231-RFP variants were developed after three serial orthotopic transplantations of lymph-node metastasis tissue. Highly-metastatic MDA-MB-231-RFP variants were isolated after seven serial orthotopic transplantations of lymph-node tissue. A: Representative whole-body images of primary tumors from parental, intermediately-metastatic and highlymetastatic MDA-MB-231-RFP tumors. B: Representative images of hemotoxylin and eosin (H&E)-stained tissue sections from primary tumors from parental, intermediately-metastatic and highly-metastatic MDA-MB-231-RFP tumors. Bar=200 μm (upper row). Bar=50 μm (lower row). C: Bar graphs show the comparison of fluorescence intensity from primary tumors (left) and lymphatic metastases (right) in mice with parental, intermediately-metastatic and highly-metastatic MDA-MB-231-RFP variant tumors. Fluorescence imaging was with the OV100
These results suggest that the number of serial orthotopic transplantations of MDA-MB-231-RFP positively correlates with aggressiveness and the intermediately and highly metastatic variants can serve as models of metastatic progression of TNBC.
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